NDRA CIK: 1681682

ENDRA Life Sciences Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.5
FY22:
−13.2
FY23:
−10.5
FY24:
−10.8
FY25:
−5.76
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.6
FY22:
−12.9
FY23:
−10.2
FY24:
−9.81
FY25:
−4.27
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.2
FY22:
−13.2
FY23:
−10.1
FY24:
−11.5
FY25:
−7.03
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.2
FY22:
−13.2
FY23:
−10.1
FY24:
−11.5
FY25:
−7.03

All amounts in millions USD Data sources:SEC EDGARTwelve Data